Colistin neurotoxicity mimicking Guillain-Barré syndrome in a patient with cystic fibrosis: Case report and review

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Guillain-Barr syndrome (GBS) is an immune-mediated polyneuropathy, which is characterized by aref lexia and ascending paresthesia which can progress to a respiratory failure. Certain conditions, such as vasculitis and heavy metal and drug toxicity,may have misleadingly similar clinical presentation to GBS.We describe a case of a patient with cystic fibrosis and intravenous colistin-induced neurotoxicity mimicking GBS. The patient had used inhaled colistin on five occasions with no adverse effects, however, developed symptoms on the second day of intravenous treatment. Overlapping findings between immune-mediated polyneuropathy and drug-induced neurotoxicity include limb paresthesia and decreased ref lexes. Perioral tingling, however, is a common presentation of colistin-induced neurotoxicity, and therefore, is an important differentiating factor. Early diagnosis prevents further neurologic decline, extensive unnecessary workup and potentially harmful incorrect management.

Cite

CITATION STYLE

APA

Camargo, C., Narula, T., Jackson, D. A., Padro, T., & Freeman, W. D. (2021, September 1). Colistin neurotoxicity mimicking Guillain-Barré syndrome in a patient with cystic fibrosis: Case report and review. Oxford Medical Case Reports. Oxford University Press. https://doi.org/10.1093/omcr/omab080

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free